Portfolio (Quarterly)
Guide ↗
Avoro Capital Advisors LLC
· CIK 0001633313| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UTHR | UNITED THERAPEUTICS CORP | Healthcare | 2,606,060.0 | $1.27B | 12.48% | NEW | — | $487.25 | +13.2% |
| 2 | — | ASCENDIS PHARMA | — | 5,111,111.0 | $1.09B | 10.71% | NEW | — | $213.24 | — |
| 3 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 1,807,500.0 | $1.05B | 10.35% | NEW | — | $582.34 | -14.2% |
| 4 | ARGX | ARGENX SE | Healthcare | 990,000.0 | $832.5M | 8.18% | NEW | — | $840.95 | +6.1% |
| 5 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 2,888,888.0 | $712.2M | 7.00% | NEW | — | $246.54 | +38.6% |
| 6 | ARWR | ARROWHEAD PHARMACEUTICALS INC | Healthcare | 10,625,000.0 | $705.4M | 6.93% | NEW | — | $66.39 | +22.1% |
| 7 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 7,474,747.0 | $581.6M | 5.72% | NEW | — | $77.81 | +15.5% |
| 8 | GPCR | STRUCTURE THERAPEUTICS INC | Healthcare | 6,555,555.0 | $455.9M | 4.48% | NEW | — | $69.55 | -35.3% |
| 9 | — | AVIDITY BIOSCIENCES INC | — | 5,455,000.0 | $393.5M | 3.87% | NEW | — | $72.13 | — |
| 10 | CNTA | CENTESSA PHARMACEUTICALS PLC | Healthcare | 14,555,555.0 | $364.0M | 3.58% | NEW | — | $25.01 | +59.4% |
| 11 | CELC | CELCUITY INC | Healthcare | 3,111,111.0 | $310.3M | 3.05% | NEW | — | $99.74 | -11.7% |
| 12 | APLS | APELLIS PHARMACEUTICALS INC | Healthcare | 12,222,222.0 | $307.0M | 3.02% | NEW | — | $25.12 | +63.3% |
| 13 | VERA | VERA THERAPEUTICS INC | Healthcare | 5,888,888.0 | $298.2M | 2.93% | NEW | — | $50.64 | -33.5% |
| 14 | XBI | SPDR SERIES TRUST - S&P BIOTECH | — | 2,100,000.0 | $256.1M | 2.52% | NEW | — | $121.93 | +14.3% |
| 15 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 5,424,444.0 | $243.1M | 2.39% | NEW | — | $44.82 | +16.0% |
| 16 | TERN | TERNS PHARMACEUTICALS INC | Healthcare | 4,350,000.0 | $175.7M | 1.73% | NEW | — | $40.40 | +31.1% |
| 17 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 2,170,000.0 | $172.8M | 1.70% | NEW | — | $79.65 | +98.1% |
| 18 | QURE | UNIQURE NV | Healthcare | 6,150,000.0 | $147.2M | 1.45% | NEW | — | $23.93 | +101.3% |
| 19 | — | SOLENO THERAPEUTICS INC | — | 2,900,000.0 | $134.3M | 1.32% | NEW | — | $46.30 | — |
| 20 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 10,777,777.0 | $130.8M | 1.29% | NEW | — | $12.14 | -20.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%